Mostrar el registro sencillo del ítem

dc.contributor.authorAraújo Meirelles, Lyghia Maria
dc.contributor.authorDe Melo Barbosa, Raquel
dc.contributor.authorSánchez Espejo, Rita María 
dc.contributor.authorGarcía Villén, Fátima
dc.contributor.authorViseras Iborra, César Antonio 
dc.date.accessioned2023-09-25T10:28:55Z
dc.date.available2023-09-25T10:28:55Z
dc.date.issued2023-07-12
dc.identifier.citationMeirelles, L.M.A.; Barbosa, R.d.M.; Sanchez-Espejo, R.; García-Villén, F.; Perioli, L.; Viseras, C.; Moura, T.F.A.d.L.e.; Raffin, F.N. Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications. Materials 2023, 16, 4962. [https://doi.org/10.3390/ma16144962]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/84638
dc.description.abstractPalygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposits in Brazil have been recorded, mainly in the country’s northeast region. This has motivated this study, which analyzes raw Brazilian palygorskite compared to a commercial sample (Pharmasorb® colloidal) to demonstrate its pharmaceutical potential. The chemical and mineral composition of the samples were evaluated for surface properties, granulometry, morphology, crystallography, thermal analysis, and spectroscopy. Raw palygorskite presented 67% purity, against 74% for Pharmasorb® colloidal. The percentage purity relates to the presence of contaminants, mainly carbonates and quartz (harmless under conventional conditions of pharmaceutical use). Furthermore, it was possible to confirm the chemical composition of these phyllosilicates, formed primarily of silicon, aluminum, and magnesium oxides. The crystallographic and spectroscopic profiles were consistent in both samples, showing characteristic peaks for palygorskite (2θ = 8.3°) and bands attributed to fibrous phyllosilicates below 1200 cm−1, respectively. The thermal analysis allowed the identification of the main events of palygorskite, with slight differences between the evaluated samples: loss of water adsorbed onto the surface (~85 °C), removal of water contained in the channels (~200 °C), coordinated water loss (~475 °C), and, finally, the dehydroxylation (>620 °C). The physicochemical characteristics of raw palygorskite align with pharmacopeial specifications, exhibiting a high specific surface area (122 m2/g), moderately negative charge (−13.1 mV), and compliance with the required limits for heavy metals and arsenic. These favorable technical attributes indicate promising prospects for its use as a pharmaceutical ingredient in the production of medicines and cosmetics.es_ES
dc.description.sponsorshipCAPES, grant number 88887.131333/2016-00es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectPalygorskitees_ES
dc.subjectExcipients es_ES
dc.subjectPharmaceutical applicationses_ES
dc.subjectClay minerales_ES
dc.titleInvestigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applicationses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3390/ma16144962
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional